Evaluation of prognostic factors and comparison of systemic treatment modalities in patients with recurrent or metastatic endometrial carcinoma


Karagol H., Saip P., Uygun K., Kucucuk S., Aydiner A., Topuz E.

MEDICAL ONCOLOGY, cilt.23, sa.4, ss.543-548, 2006 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 23 Sayı: 4
  • Basım Tarihi: 2006
  • Doi Numarası: 10.1385/mo:23:4:543
  • Dergi Adı: MEDICAL ONCOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.543-548
  • Anahtar Kelimeler: endometrial carcinoma, metastasis or recurrence, prognostic factors, systemic treatment, GYNECOLOGIC-ONCOLOGY-GROUP, PHASE-II TRIAL, CANCER, CHEMOTHERAPY
  • Kocaeli Üniversitesi Adresli: Evet

Özet

Background: Prognostic factors related to survival in patients with inoperable metastatic or recurrent endometrial carcinoma (MREC) have remained unclear due to lack of clinical trials.The management of these patients is also controversial.This study was performed to compare the efficacy and toxicity profiles of two different systemic therapies (chemotherapy vs hormonal therapy) given for the treatment of patients with MREC and to identify the impact of various prognostic factors on the survival.